aluates Reports

$ 0.0

Automative

Global Endometriosis Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-3O6487

Global Endometriosis Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Endometriosis Drugs Market Research Report 2025

Code: QYRE-Auto-3O6487

Report

September 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Astellas Pharma

Astrazeneca plc

Debiopharm Group

Evotec AG

Kissei Pharmaceutical

Neurocrine Biosciences

ObsEva

Pfizer Inc

Repros Therapeutics

Roivant Sciences

Takeda Pharmaceutical Company

ValiRx Plc

Endometriosis Drugs Market Size

The global market for Endometriosis Drugs was valued at US$ 1949 million in the year 2024 and is projected to reach a revised size of US$ 2304 million by 2031, growing at a CAGR of 2.5% during the forecast period.

Endometriosis Drugs Market

Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Endometriosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometriosis Drugs.

The Endometriosis Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endometriosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Endometriosis Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Endometriosis Drugs Market Report

Report Metric	Details
Report Name	Endometriosis Drugs Market
Accounted market size in year	US$ 1949 million
Forecasted market size in 2031	US$ 2304 million
CAGR	2.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Hormonal Therapy Add-back Medication Progestogens Chinese Herbs
Segment by Application	Hospitals Clinics Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Astellas Pharma, AstraZeneca, Debiopharm Group, Evotec, Kissei Pharmaceutical, Neurocrine Biosciences, ObsEva, Pfizer, Repros Therapeutics, Roivant Sciences, Takeda Pharmaceutical Company, ValiRx
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endometriosis Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Endometriosis Drugs Market growing?

Ans: The Endometriosis Drugs Market witnessing a CAGR of 2.5% during the forecast period 2025-2031.

What is the Endometriosis Drugs Market size in 2031?

Ans: The Endometriosis Drugs Market size in 2031 will be US$ 2304 million.

Who are the main players in the Endometriosis Drugs Market report?

Ans: The main players in the Endometriosis Drugs Market are AbbVie, Astellas Pharma, AstraZeneca, Debiopharm Group, Evotec, Kissei Pharmaceutical, Neurocrine Biosciences, ObsEva, Pfizer, Repros Therapeutics, Roivant Sciences, Takeda Pharmaceutical Company, ValiRx

What are the Application segmentation covered in the Endometriosis Drugs Market report?

Ans: The Applications covered in the Endometriosis Drugs Market report are Hospitals, Clinics, Research Institutes

What are the Type segmentation covered in the Endometriosis Drugs Market report?

Ans: The Types covered in the Endometriosis Drugs Market report are Hormonal Therapy, Add-back Medication, Progestogens, Chinese Herbs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hormonal Therapy

1.2.3 Add-back Medication

1.2.4 Progestogens

1.2.5 Chinese Herbs

1.3 Market by Application

1.3.1 Global Endometriosis Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Endometriosis Drugs Market Perspective (2020-2031)

2.2 Global Endometriosis Drugs Growth Trends by Region

2.2.1 Global Endometriosis Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Endometriosis Drugs Historic Market Size by Region (2020-2025)

2.2.3 Endometriosis Drugs Forecasted Market Size by Region (2026-2031)

2.3 Endometriosis Drugs Market Dynamics

2.3.1 Endometriosis Drugs Industry Trends

2.3.2 Endometriosis Drugs Market Drivers

2.3.3 Endometriosis Drugs Market Challenges

2.3.4 Endometriosis Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Endometriosis Drugs Players by Revenue

3.1.1 Global Top Endometriosis Drugs Players by Revenue (2020-2025)

3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Endometriosis Drugs Revenue

3.4 Global Endometriosis Drugs Market Concentration Ratio

3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2024

3.5 Global Key Players of Endometriosis Drugs Head office and Area Served

3.6 Global Key Players of Endometriosis Drugs, Product and Application

3.7 Global Key Players of Endometriosis Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Endometriosis Drugs Breakdown Data by Type

4.1 Global Endometriosis Drugs Historic Market Size by Type (2020-2025)

4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2026-2031)

5 Endometriosis Drugs Breakdown Data by Application

5.1 Global Endometriosis Drugs Historic Market Size by Application (2020-2025)

5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Endometriosis Drugs Market Size (2020-2031)

6.2 North America Endometriosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Endometriosis Drugs Market Size by Country (2020-2025)

6.4 North America Endometriosis Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Endometriosis Drugs Market Size (2020-2031)

7.2 Europe Endometriosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Endometriosis Drugs Market Size by Country (2020-2025)

7.4 Europe Endometriosis Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Endometriosis Drugs Market Size (2020-2031)

8.2 Asia-Pacific Endometriosis Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Endometriosis Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Endometriosis Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Endometriosis Drugs Market Size (2020-2031)

9.2 Latin America Endometriosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Endometriosis Drugs Market Size by Country (2020-2025)

9.4 Latin America Endometriosis Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Endometriosis Drugs Market Size (2020-2031)

10.2 Middle East & Africa Endometriosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Endometriosis Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Endometriosis Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Endometriosis Drugs Introduction

11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Details

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Endometriosis Drugs Introduction

11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2020-2025)

11.2.5 Astellas Pharma Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Endometriosis Drugs Introduction

11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2020-2025)

11.3.5 AstraZeneca Recent Development

11.4 Debiopharm Group

11.4.1 Debiopharm Group Company Details

11.4.2 Debiopharm Group Business Overview

11.4.3 Debiopharm Group Endometriosis Drugs Introduction

11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2020-2025)

11.4.5 Debiopharm Group Recent Development

11.5 Evotec

11.5.1 Evotec Company Details

11.5.2 Evotec Business Overview

11.5.3 Evotec Endometriosis Drugs Introduction

11.5.4 Evotec Revenue in Endometriosis Drugs Business (2020-2025)

11.5.5 Evotec Recent Development

11.6 Kissei Pharmaceutical

11.6.1 Kissei Pharmaceutical Company Details

11.6.2 Kissei Pharmaceutical Business Overview

11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction

11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2020-2025)

11.6.5 Kissei Pharmaceutical Recent Development

11.7 Neurocrine Biosciences

11.7.1 Neurocrine Biosciences Company Details

11.7.2 Neurocrine Biosciences Business Overview

11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction

11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2020-2025)

11.7.5 Neurocrine Biosciences Recent Development

11.8 ObsEva

11.8.1 ObsEva Company Details

11.8.2 ObsEva Business Overview

11.8.3 ObsEva Endometriosis Drugs Introduction

11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2020-2025)

11.8.5 ObsEva Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Endometriosis Drugs Introduction

11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2020-2025)

11.9.5 Pfizer Recent Development

11.10 Repros Therapeutics

11.10.1 Repros Therapeutics Company Details

11.10.2 Repros Therapeutics Business Overview

11.10.3 Repros Therapeutics Endometriosis Drugs Introduction

11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2020-2025)

11.10.5 Repros Therapeutics Recent Development

11.11 Roivant Sciences

11.11.1 Roivant Sciences Company Details

11.11.2 Roivant Sciences Business Overview

11.11.3 Roivant Sciences Endometriosis Drugs Introduction

11.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2020-2025)

11.11.5 Roivant Sciences Recent Development

11.12 Takeda Pharmaceutical Company

11.12.1 Takeda Pharmaceutical Company Company Details

11.12.2 Takeda Pharmaceutical Company Business Overview

11.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction

11.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2020-2025)

11.12.5 Takeda Pharmaceutical Company Recent Development

11.13 ValiRx

11.13.1 ValiRx Company Details

11.13.2 ValiRx Business Overview

11.13.3 ValiRx Endometriosis Drugs Introduction

11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2020-2025)

11.13.5 ValiRx Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Astellas Pharma

Astrazeneca plc

Debiopharm Group

Evotec AG

Kissei Pharmaceutical

Neurocrine Biosciences

ObsEva

Pfizer Inc

Repros Therapeutics

Roivant Sciences

Takeda Pharmaceutical Company

ValiRx Plc

List of Tables

Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hormonal Therapy

Table 3. Key Players of Add-back Medication

Table 4. Key Players of Progestogens

Table 5. Key Players of Chinese Herbs

Table 6. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Endometriosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Endometriosis Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Endometriosis Drugs Market Share by Region (2020-2025)

Table 10. Global Endometriosis Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Endometriosis Drugs Market Share by Region (2026-2031)

Table 12. Endometriosis Drugs Market Trends

Table 13. Endometriosis Drugs Market Drivers

Table 14. Endometriosis Drugs Market Challenges

Table 15. Endometriosis Drugs Market Restraints

Table 16. Global Endometriosis Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Endometriosis Drugs Market Share by Players (2020-2025)

Table 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2024)

Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Endometriosis Drugs, Headquarters and Area Served

Table 22. Global Key Players of Endometriosis Drugs, Product and Application

Table 23. Global Key Players of Endometriosis Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Endometriosis Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Endometriosis Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Endometriosis Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Endometriosis Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Endometriosis Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Endometriosis Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Endometriosis Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Endometriosis Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Endometriosis Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Endometriosis Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Endometriosis Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Endometriosis Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Endometriosis Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Endometriosis Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Endometriosis Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Endometriosis Drugs Product

Table 51. AbbVie Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Astellas Pharma Company Details

Table 54. Astellas Pharma Business Overview

Table 55. Astellas Pharma Endometriosis Drugs Product

Table 56. Astellas Pharma Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 57. Astellas Pharma Recent Development

Table 58. AstraZeneca Company Details

Table 59. AstraZeneca Business Overview

Table 60. AstraZeneca Endometriosis Drugs Product

Table 61. AstraZeneca Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 62. AstraZeneca Recent Development

Table 63. Debiopharm Group Company Details

Table 64. Debiopharm Group Business Overview

Table 65. Debiopharm Group Endometriosis Drugs Product

Table 66. Debiopharm Group Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 67. Debiopharm Group Recent Development

Table 68. Evotec Company Details

Table 69. Evotec Business Overview

Table 70. Evotec Endometriosis Drugs Product

Table 71. Evotec Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 72. Evotec Recent Development

Table 73. Kissei Pharmaceutical Company Details

Table 74. Kissei Pharmaceutical Business Overview

Table 75. Kissei Pharmaceutical Endometriosis Drugs Product

Table 76. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 77. Kissei Pharmaceutical Recent Development

Table 78. Neurocrine Biosciences Company Details

Table 79. Neurocrine Biosciences Business Overview

Table 80. Neurocrine Biosciences Endometriosis Drugs Product

Table 81. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 82. Neurocrine Biosciences Recent Development

Table 83. ObsEva Company Details

Table 84. ObsEva Business Overview

Table 85. ObsEva Endometriosis Drugs Product

Table 86. ObsEva Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 87. ObsEva Recent Development

Table 88. Pfizer Company Details

Table 89. Pfizer Business Overview

Table 90. Pfizer Endometriosis Drugs Product

Table 91. Pfizer Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 92. Pfizer Recent Development

Table 93. Repros Therapeutics Company Details

Table 94. Repros Therapeutics Business Overview

Table 95. Repros Therapeutics Endometriosis Drugs Product

Table 96. Repros Therapeutics Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 97. Repros Therapeutics Recent Development

Table 98. Roivant Sciences Company Details

Table 99. Roivant Sciences Business Overview

Table 100. Roivant Sciences Endometriosis Drugs Product

Table 101. Roivant Sciences Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 102. Roivant Sciences Recent Development

Table 103. Takeda Pharmaceutical Company Company Details

Table 104. Takeda Pharmaceutical Company Business Overview

Table 105. Takeda Pharmaceutical Company Endometriosis Drugs Product

Table 106. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 107. Takeda Pharmaceutical Company Recent Development

Table 108. ValiRx Company Details

Table 109. ValiRx Business Overview

Table 110. ValiRx Endometriosis Drugs Product

Table 111. ValiRx Revenue in Endometriosis Drugs Business (2020-2025) & (US$ Million)

Table 112. ValiRx Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Endometriosis Drugs Picture

Figure 2. Global Endometriosis Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Endometriosis Drugs Market Share by Type: 2024 VS 2031

Figure 4. Hormonal Therapy Features

Figure 5. Add-back Medication Features

Figure 6. Progestogens Features

Figure 7. Chinese Herbs Features

Figure 8. Global Endometriosis Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Endometriosis Drugs Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Research Institutes Case Studies

Figure 13. Endometriosis Drugs Report Years Considered

Figure 14. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Endometriosis Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Endometriosis Drugs Market Share by Region: 2024 VS 2031

Figure 17. Global Endometriosis Drugs Market Share by Players in 2024

Figure 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2024

Figure 20. North America Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Endometriosis Drugs Market Share by Country (2020-2031)

Figure 22. United States Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Endometriosis Drugs Market Share by Country (2020-2031)

Figure 26. Germany Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Endometriosis Drugs Market Share by Region (2020-2031)

Figure 34. China Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Endometriosis Drugs Market Share by Country (2020-2031)

Figure 42. Mexico Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Endometriosis Drugs Market Share by Country (2020-2031)

Figure 46. Turkey Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Endometriosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 50. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 51. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 52. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 53. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 54. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 55. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 56. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 58. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 59. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 60. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 61. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Endometriosis Treatment Market Research Report 2025

Global Gynecological Conditions Medications Market Research Report 2024

Global Adenomyosis Drugs Market Research Report 2024

Global Endometrial Cancer Therapeutics Market Research Report 2025

Global Female Infertility Drugs Market Insights Forecast to 2030

Global Uterine Fibroids Drug Market Research Report 2024

Global Women s Health Care Drugs Market Research Report 2024

Global Female Contraception Market Research Report 2024

Global Dysmenorrhea Treatment Market Research Report 2024

Global Female Contraception Drug Market Research Report 2024

Global Endometrial Ablation System Market Research Report 2025

Global Uterine Fibroid Treatment Market Research Report 2025

Global Women s Health Products Market Research Report 2024

Global Endometrial Resection Device Market Research Report 2025

Global Robotic Surgery Systemsfor Endometrial Cancer Market Research Report 2025

Amenorrhea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polycystic Ovary Syndrome Treatment Market Insights Forecast to 2030

Global Obstetrics and Gynecology Drugs Market Research Report 2025

Global Menopausal Medications Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions